Karine Blouin

Dr. Karine Blouin

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2008 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
KBKarine Blouin
Karine Blouin
ABAriane Boivin
Ariane Boivin
ATAndré Tchernof
André Tchernof

19 January 2010 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
KBKarine Blouin
Karine Blouin
MNMélanie Nadeau
Mélanie Nadeau
MPMartin Perreault
Martin Perreault
AVAlain Veilleux
Alain Veilleux
RDRenée Drolet
Renée Drolet
ATAndré Tchernof
André Tchernof

1 August 2005 in Metabolism
Verified
Journal Article
Closed access
KBKarine Blouin
Karine Blouin
JDJean-Pierre Després
Jean-Pierre Després
CCCharles Couillard
Charles Couillard
ATAngelo Tremblay
Angelo Tremblay
DPDenis Prud'HOmme
Denis Prud'HOmme
ATAndré Tchernof
André Tchernof

1 March 2009 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
KBKarine Blouin
Karine Blouin
AVAlain Veilleux
Alain Veilleux
VLVan Luu-The
Van Luu-The
ATAndré Tchernof
André Tchernof

1 February 2009 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
KBKarine Blouin
Karine Blouin
MNMélanie Nadeau
Mélanie Nadeau
JMJacques Mailloux
Jacques Mailloux
MDMarleen Daris
Marleen Daris
SLStephane Lebel
Stephane Lebel
ATAndré Tchernof
André Tchernof
The objective was to examine pathways of androgen metabolism in abdominal adipose tissue in women. Abdominal subcutaneous (SC) and omental (OM) adipose tissue samples were surgically obtained in women. Total RNA was isolated from whole adipose tissue samples and from primary preadipocyte cultures before and after induction of differentiation. Expression levels of several steroid-converting enzyme transcripts were examined by real-time RT-PCR. Androgen conversion rates were also measured. We found higher expression levels in SC compared with OM adipose tissue for type 1 3β-hydroxysteroid dehydrogenase (3β-HSD-1; P < 0.05), for aldo-keto reductase 1C3 (AKR1C3; P < 0.0001), for AKR1C2 ( P < 0.0001), and for the androgen receptor ( P < 0.0001). 17β-HSD-2 mRNA levels were lower in SC adipose tissue ( P < 0.05). Induction of adipocyte differentiation led to significantly increased expression levels in SC cultures for AKR1C3 (4.7-fold, P < 0.01), 11- cis-retinol dehydrogenase (6.9-fold, P < 0.02), AKR1C2 (5.6-fold, P < 0.004), P-450 aromatase (5.7-fold, P < 0.02), steroid sulfatase (3.1-fold, P < 0.02), estrogen receptor-β (11.8-fold, P < 0.01), and the androgen receptor (4.0-fold, P < 0.0005). Generally similar but nonsignificant trends were obtained in OM cultures. DHT inactivation rates increased with differentiation, this effect being mediated by dexamethasone alone, through a glucocorticoid receptor-dependent mechanism. In conclusion, higher mRNA levels of enzymes synthesizing and inactivating androgens are found in differentiated adipocytes, consistent with higher androgen-processing rates in these cells. Glucocorticoid-induced androgen inactivation may locally modulate the exposure of adipose cells to active androgens.

1 December 2006 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
KBKarine Blouin
Karine Blouin
CRChristian Richard
Christian Richard
GBGaétan Brochu
Gaétan Brochu
FHFrédéric-Simon Hould
Frédéric-Simon Hould
SLStéfane Lebel
Stéfane Lebel
ATAndré Tchernof
André Tchernof
We examined 5α-dihydrotestosterone (5α-DHT) inactivation and the expression of several steroid-converting enzymes with a focus on aldoketoreductases 1C (AKR1C), especially AKR1C2, in abdominal adipose tissue in men. AKR1C2 is mainly involved in the conversion of the potent androgen 5α-DHT to its inactive forms 5α-androstane-3α/β,17β-diol (3α/β-diol). Subcutaneous (s.c.) and omental (Om) adipose tissue biopsies were obtained from 21 morbidly obese men undergoing biliopancreatic derivation surgery and 11 lean to obese men undergoing general abdominal surgery. AKR1C2 mRNA and 5α-DHT inactivation were detected in both s.c. and Om adipose tissue. After incubation of preadipocytes with 5α-DHT, both 3α-diol and 3β-diol were produced through 3α/β-ketosteroid reductase (3α/β-HSD) activity. In preadipocyte cultures, 3α-reductase activity was significantly predominant over 3β-reductase activity in cells from both the s.c. and Om compartments. Expression levels of AKR1C1, AKR1C3 and of the androgen receptor were significantly higher in s.c. versus Om adipose tissue while mRNA levels of 17β-HSD-2 (hydroxysteroid dehydrogenase type 2) and 3(α→β)-hydroxysteroid epimerase were significantly higher in Om fat. 3α/β-HSD activity was mainly detected in the cytosolic fraction, suggesting that AKR1C may be responsible for this reaction. Experiments with isoform-specific AKR1C inhibitors in preadipocytes showed that AKR1C2 inhibition significantly decreased 3α-HSD and 3β-HSD activities (3α-HSD: 30 ± 24% of control for s.c. and 32 ± 9% of control for Om, 3β-HSD: 44 ± 12% of control for s.c.). When cells were incubated with both AKR1C2 and AKR1C3 inhibitors, no significant additional inhibition was observed. 5α-DHT inactivation was significantly higher in mature adipocytes compared with preadipocyte cultures in s.c. adipose tissue, as expressed per microgram total protein (755 ± 830 versus 245 ± 151 fmol 3α/β-diol per μg protein over 24 h, P < 0.05 n = 10 cultures). 5α-DHT inactivation measured in tissue homogenates was significantly higher in the s.c. depot compared with Om fat (117 ± 39 versus 79 ± 38 fmol 3α/β-diol per μg prot over 24 h, P < 0.0001). On the other hand, Om 3α/β-HSD activity was significantly higher in obese men (body mass index (BMI) ≥ 30 kg/m2) compared with lean and overweight men (84 ± 37 versus 52 ± 30 fmol 3α/β-diol per μg protein over 24 h, P < 0.03). No difference was found in s.c. 3α/β-HSD activity between these groups. Positive correlations were found between s.c. 5α-DHT inactivation rate and circulating levels of the androgen metabolites androsterone-glucuronide (r = 0.41, P < 0.02) and 3α-diol-glucuronide (r = 0.38, P < 0.03) and with the adrenal precursor androstenedione (r = 0.42, P < 0.02). In conclusion, androgen inactivation was detected in abdominal adipose tissue in men, with higher 3α/β-HSD activity in the s.c. versus Om depot. Higher Om 5α-DHT inactivation rates were found in obese compared with lean men. Further studies are required to elucidate whether local androgen inactivation in abdominal adipose tissue is involved in the modulation of adipocyte metabolism and regional fat distribution in men.